You searched for "diagnostic"
Anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis: a retrospective medical records review
Optic neuritis causes acute loss of visual function and can result in devastating visual dysfunction. Recently, measurements of anti-aquaporin 4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies have become available, making it possible to evaluate the disease pathogenesis. This paper...
Long-term treatment for diabetic macular oedema
The authors set out to characterise anti-VEGF treatment patterns and long-term outcomes in patients with diabetic macular oedema. A retrospective analysis of over 190 thousand patients on the Intelligent Research in Sight registry was performed. Of these, 1236 eyes have...
Systematic review of management options for intermittent exotropia
The authors conduct a robust systematic review of the literature to report evidence on non-surgical and surgical treatment options for intermittent exotropia – divergence excess and basic intermittent exotropia types. Discussion centres on (1) optical correction of refractive error with...
OCTA and pigment epithelium detachments
Yannuzzi et al. report on their study aiming to evaluate the ability of optical coherence tomography angiography (OCTA) to differentiate vascularised from nonvascularised pigment epithelium detachments (PEDs) using conventional imaging techniques, including fundus fluorescein angiography (FFA) and indocyanine green (ICG),...
Recommendation for wide angle fluorescein angiography to diagnose FEVR in NEDSDV
Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) is a genetic disease described in 2012 associated with variants in the CTNNB1 gene which encodes beta-catenin. Characteristics include strabismus, reduced visual acuity and familial exudative retinopathy (FEVR). In this study,...
Identification of potential social determinants which may impact on idiopathic intracranial hypertension
The authors analysed cross-sectional data with the aim of exploring the social determinants of idiopathic intracranial hypertension (IIH). The data was obtained from the National Institute of Health (NIH) All of Us research programme (version 6 – May 2018 to...Cybersight: Clinical Technology & Surgical Techniques in the Evolving Management of Corneal Diseases
The current state of the art in the diagnosis and treatment of corneal diseases depends on imaging techniques to visualize the morphology, 3D structure, and optical quality of the cornea. Improvements in imaging allow for increasingly individualized treatment of corneal...Moorfields Education International Uveitis Symposium
Don't miss this chance to hear from top national and international speakers, including symposium organiser Professor Carlos Pavesio, Consultant Ophthalmologist and uveitis specialist at Moorfields Eye Hospital and Director of the Scientific Organizing Committee. This unique three day symposium will provide a forum for the exchange of information and new ideas relevant to clinical practice, investigations, and therapeutic management of patients with ocular inflammatory diseases and complex uveitic conditions, with an in-depth discussion surrounding the diagnosis and therapeutic strategies of specific inflammatory disorders.Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US
Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...From paper to digital: Real lessons for a sustainable NHS digital future
Portsmouth's OpenEyes implementation reveals why healthcare digital transformation needs honest evaluation, proper clinical leadership resourcing and realistic expectations about technology efficiency promises. Like many eye departments across the NHS, we at Portsmouth were drowning in paper. Notes went missing, handwriting...Semaglutide and vision loss: A new concern for NAION risk?
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...
